New drug combo tested to shrink rectal tumors before surgery
NCT ID NCT03516708
Summary
This study is testing if adding an experimental drug called epacadostat to the standard pre-surgery treatment (chemotherapy and radiation) works better for people with locally advanced rectal cancer. The main goals are to find the safest dose of the new combination and to see if it helps shrink tumors more effectively before surgery. About 49 adults with newly diagnosed rectal cancer that hasn't spread are being recruited.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Henry Ford Cancer Institute
WITHDRAWNDetroit, Michigan, 48202, United States
-
University of California Irvine - Chao Family Comprehensive Cancer Center
WITHDRAWNOrange, California, 92868, United States
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.